The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
NCT05100719
Carbohydrate Metabolism, Inborn Errors, Colonic Diseases
Pécs, Hungary
View Trial DetailsNCT Number: NCT06931379
This cross-sectional study aims to determine the prevalence of lactose intolerance among patients with chronic diarrhea, assess its correlation with age and gender, and evaluate common symptoms in affected patients. The study will collect demographic data, conduct lactose intolerance testing via PCR, and use a symptom questionnaire.
Trial opening soon.
Get Notified18 year–70 year
All sexes
Observational
The study is designed as a cross-sectional analysis conducted at a single healthcare center. Its primary objectives are:
To determine the point prevalence of lactose intolerance in patients suffering from chronic diarrhea (lasting more than four weeks).
To explore potential correlations between lactose intolerance and demographic factors such as age and gender.
To identify the most common symptoms associated with lactose intolerance in this patient population.
Methodology:
Data Collection: Demographic information (age, sex, medical history, and diarrhea duration) will be gathered.
Lactose Intolerance Testing: Polymerase Chain Reaction (PCR) will be employed to diagnose lactose intolerance.
Symptom Questionnaire: A standardized questionnaire will be administered to document symptoms like abdominal pain, bloating, flatulence, diarrhea, and nausea.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
The primary outcome is to determine the percentage of patients with chronic diarrhea who test positive for lactose intolerance using PCR testing.
Assiut University
Other
Screening for Lactose Intolerance Among Patients With IBS Diarrhea Dominant
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05100719
Carbohydrate Metabolism, Inborn Errors, Colonic Diseases
Pécs, Hungary
View Trial DetailsNCT07652827
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Concepción, Chile
View Trial DetailsNCT06513026
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
The Bronx, New York, United States
View Trial DetailsNCT07494123
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Cairo, Cairo Governorate, Egypt
View Trial Details